AstraZeneca

Is ReNeuron Group plc a better buy than AstraZeneca plc?

Should you ditch AstraZeneca plc (LON: AZN) in favour of ReNeuron Group plc (LON: RENE)? More »

These 3 FTSE 100 stocks are ridiculously cheap!

Royston Wild discusses three FTSE 100 (INDEXFTSE: UKX) dealing at rock-bottom prices. More »

Is AstraZeneca plc or GlaxoSmithKline plc the best Black Friday buy?

Will AstraZeneca plc (LON: AZN) or GlaxoSmithKline plc (LON: GSK) soar over the medium-to-long term? More »

Are these 2 stocks the income heroes your portfolio needs?

These two stocks pay income of more than 5% a year. Harvey Jones examines whether this rate of return is sustainable. More »

Should you dump AstraZeneca plc and buy BTG plc after 10% sales rise?

Does BTG plc (LON: BTG) offer superior growth potential to AstraZeneca plc (LON: AZN)? More »

Clinigen Group plc vs AstraZeneca plc: which is the hotter healthcare stock?

Royston Wild considers the investment potential of medicine mammoths Clinigen Group plc (LON: CLIN) and AstraZeneca plc (LON: AZN). More »

Why AstraZeneca plc may still not be cheap enough to beat this upstart

Roland Head takes a look at the latest figures from AstraZeneca plc (LON:AZN) and considers a potential alternative. More »

Should you invest in pills or joints?

Which of these stocks should be on your shopping list today? More »

2 firms to hold until you retire and beyond

Brexit looks like a sideshow for these enduring businesses. More »

These FTSE 100 stocks sank in October. Time to stock up?

Royston Wild runs the rule over two recent FTSE 100 (INDEXFTSE: UKX) losers. More »

The Good, the Bad and the Ugly of pharma stocks

Bilaal Mohamed reveals his best and worst picks from the pharmaceuticals sector. More »

Should you buy this stock after it reports a 27% rise in revenue?

Is this company set to soar after positive results? More »

Forget short-term pain! Buy these FTSE 100 stars for long-term gain

Royston Wild looks at two brilliant FTSE 100 (INDEXFTSE: UKX) stocks for long-term investors. More »

These FTSE 100 beauties are just too cheap to miss!

Royston Wild reveals two FTSE 100 (INDEXFTSE: UKX) firecrackers trading far, far too cheaply. More »

These dividend stocks won’t yield 4%+ forever

Getting a 4%+ yield from these shares beats savings accounts, but may not be available for much longer. More »

These two FTSE 100 dividends stars still look cheap

These two FTSE 100 (INDEXFTSE: UKX) firms look like safe dividend champions but still appear to be undervalued. More »

Do these 3 low yielders offer high growth prospects?

A sky-high yield isn't everything these days, is it? Harvey Jones investigates. More »

Is this a better healthcare buy than AstraZeneca plc after today’s update?

Will this healthcare stock keep beating AstraZeneca plc (LON: AZN)? More »

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN) in the pharma stakes? More »

These two large caps look seriously undervalued

These two large caps could be the most undervalued in the FTSE 100. More »